Instead, the ratio of CD3+ lymphocytes to FOXP3+ Treg was a better predictor of disease-free survival than tumor stage or lymph node spread [28], and high intratumoral CD8+ to Treg ratios also correlate to better survival [37]. This evidence concerns the gene FOXP3 and neoplasm.